Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blood Loss
Open-data reference.
9 US clinical trials · 2 currently recruiting
Active & Recent Trials
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
University of California, San Diego
NCT06820177
Oxytocin Pharmacokinetics and Pharmacodynamics
University of Chicago
NCT05488457
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
Campbell Clinic
NCT05099276
LBNP Tolerance With Skin Warming After Exercise Cold Stress
University of Colorado, Colorado Springs
NCT06279897
Oral Versus Intravenous Tranexamic Acid
Hospital for Special Surgery, New York
NCT04089865
Frozen Red Blood Cell Transfusions in Trauma Patients
Oregon Health and Science University
NCT01038557
Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients
Zynex Monitoring Solutions
NCT04706221
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
University of Texas Southwestern Medical Center
NCT03856164
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
University of Hawaii
NCT04651166
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Blood Loss Trial Landscape
ClinicalTrials.gov lists 9 US studies indexed under Blood Loss, and 2 of those are currently open to recruitment — roughly 22% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Blood Loss shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Blood Loss is led by Zynex Monitoring Solutions with 1 indexed trial, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 9 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Blood Loss?
PlainTrial tracks 9 US clinical trials for Blood Loss, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Blood Loss?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.